Faron Pharmaceuticals Oy
Company Profile
Business description
Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company developing novel treatments for medical conditions with unmet needs. The company has a pipeline based on the receptors involved in the regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy in phase I/II development as a novel macrophage checkpoint immunotherapy for patients with untreatable solid tumours, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Traumakine, the company's investigational intravenous interferon beta-1a is an anti-viral and anti-inflammatory agent, being tested for the prevention of complications that arise from cytokine release syndrome, or hyperinflammatory conditions.
Contact
Joukahaisenkatu 6 B
Turku 20520
FINT: +358 24695151
E: investor.relations@faron.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
34
Stocks News & Analysis
stocks
5 star stocks from very different top-rated funds
video
Will obesity drugs derail ResMed?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,013.80 | 11.00 | 0.14% |
| CAC 40 | 7,479.40 | 51.32 | -0.68% |
| DAX 40 | 18,235.45 | 24.90 | 0.14% |
| Dow JONES (US) | 39,118.86 | 45.20 | -0.12% |
| FTSE 100 | 8,164.12 | 15.56 | -0.19% |
| HKSE | 17,718.61 | 2.14 | 0.01% |
| NASDAQ | 17,732.60 | 126.08 | -0.71% |
| Nikkei 225 | 39,583.08 | 241.54 | 0.61% |
| NZX 50 Index | 11,717.43 | 117.59 | -0.99% |
| S&P 500 | 5,460.48 | 22.39 | -0.41% |
| S&P/ASX 200 | 7,767.50 | 7.90 | 0.10% |
| SSE Composite Index | 2,967.40 | 21.55 | 0.73% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Peninsula Energy Ltd PEN | 0.11 | 0.01 | 5.00% |
| Sayona Mining Ltd SYA | 0.04 | 0.00 | -5.26% |
| Imugene Ltd IMU | 0.06 | 0.00 | 5.56% |
| The Star Entertainment Group Ltd SGR | 0.49 | 0.01 | 2.08% |
| Mirvac Group MGR | 1.87 | 0.06 | 3.31% |
| Core Lithium Ltd CXO | 0.09 | 0.01 | -5.10% |
| Pilbara Minerals Ltd PLS | 3.07 | 0.19 | -5.83% |
| Liontown Resources Ltd LTR | 0.91 | 0.02 | -2.16% |
| Bowen Coking Coal Ltd BCB | 0.05 | 0.00 | 1.96% |
| Red 5 Ltd RED | 0.36 | 0.01 | -2.70% |